Approved, Seladelpar Can Provide an Important Treatment Option for People Living With the Rare Liver Disease in the European Economic Area – ...
Gilead Sciences (GILD) said on Friday that the European Commission (EC) granted conditional marketing authorization for ...
On the downside, the US Dollar Index may test the lower boundary of the descending channel at 106.10, followed by the key psychological level of 106.00. A break below this critical support zone could ...
Celltrion expands its reach in Europe, securing marketing authorization from the European Commission (EC) for its denosumab biosimilar candidate (Stoboclo and Osenvelt) and its aflibercept biosimilar ...
Biliary tract cancer is increasing in incidence and mortality across Europe, with more people under the age of 60 years old ...
This contract has experienced an incredible rally since Jan. 22, however, the forward curve is pointing sharply downwards ...
Researchers have suggested that uniform evidence standards and reporting requirements could help speed patient access to cell ...
Apellis Pharmaceuticals, Inc. (Nasdaq: APLS) and Sobi ® (STO:SOBI) today announced the European Medicines Agency (EMA) has validated an indication extension application for Aspaveli ® (pegcetacoplan) ...
C3i obtained a Drug Establishment License (DEL) to produce cell therapies for patients across Canada commercially.